Rockefeller Capital Management L.P. Alkermes Plc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$21.94 - $26.24 $7,459 - $8,921	-340 Reduced 88.08%	46 $1,000
Q3 2022 Nov 02, 2022	BUY	$22.0 - $31.87 $726 - $1,051	33 Added 9.35%	386 $8,000
Q2 2022 Aug 12, 2022	SELL	$26.4 - $30.54 $792 - $916	-30 Reduced 7.83%	353 $10,000
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $8,835 - $10,720	383 New	383 $10,000
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $8,202 - $11,277	-351 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$18.78 - $25.15 $4,864 - $6,513	259 Added 281.52%	351 $8,000
Q1 2021 May 11, 2021	BUY	$18.21 - $23.2 $1,675 - $2,134	92 New	92 $1,000
Q1 2019 May 10, 2019	SELL	$28.4 - $36.49 $52,540 - $67,506	-1,850 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$53.61 - $67.26 $99,178 - $124,431	1,850 New	1,850 $107,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.